Tweets All / No replies
-
Read our latest article - Case Study of Dr. Iavarone's work on a
#genefusion in#GBM http://ow.ly/hVrBNRetweeted by National Cancer InstExpand Collapse -
NCI researchers seek parties to develop small antibody fragments that are potentially useful as cancer therapeutics. http://1.usa.gov/11XN2GV
Retweeted by National Cancer InstExpand Collapse -
NCI seeks partners for Microscope Software for Cancer Diagnosis, a set of tools for assays on new unseen datasets. http://1.usa.gov/ZkltlK
Retweeted by National Cancer InstExpand Collapse -
New NCI collaboration opportunity: polyvinylpyrrolidone-based polymer that releases NO when applied to a moist wound. http://1.usa.gov/Zklwhc
Retweeted by National Cancer InstExpand Collapse -
A new co-development opportunity to work with NCI on a vaccine that selectively destroys metastasizing cells. http://1.usa.gov/Ydp85F
Retweeted by National Cancer InstExpand Collapse -
From http://cancer.gov : A new fact sheet on breast reconstruction following a mastectomy http://1.usa.gov/11XL2yg
-
MT
@ncibiospecimens: Learn more about the Cooperative Group Banks, run by the Cancer Diagnosis Program, http://1.usa.gov/11XywPh#CDP#CGB -
Call for pilot and feasibility studies in
#metabolomics (up to $50K per award). Hurry--deadline is 3/1/2013. http://1.usa.gov/YdKdLvRetweeted by National Cancer InstExpand Collapse -
Cancer vaccine clinical trial enrolling adults with persistent or recurrent cancer http://1.usa.gov/TdXrYb
#cancerresearchRetweeted by National Cancer InstExpand Collapse -
We need partners to co-develop a diagnostic tool that can identify new drugs that increase chromosome instability. http://1.usa.gov/YdwYKG
Retweeted by National Cancer InstExpand Collapse -
New test for cancer-causing endocrine-disrupting chemicals in our water. A co-development opportunity with NCI. http://1.usa.gov/11XnJEL
Retweeted by National Cancer InstExpand Collapse -
Featured clinical trial: Refining post-surgical therapy for women w/ lymph node-positive breast
#cancer http://1.usa.gov/11Xoo96 -
Rabbit monoclonal antibodies for therapeutic agents against mesothelin-expressing cancers. http://1.usa.gov/YIIwEv
Retweeted by National Cancer InstExpand Collapse -
Immune response regulation research needs co-development partners at NCI's Laboratory of Molecular Immunoregulation http://1.usa.gov/12RoVJi
Retweeted by National Cancer InstExpand Collapse -
A
@PNASNews paper from#MIT#PSOC: "Impact of deleterious passenger mutations on cancer progression" http://bit.ly/1378it5Retweeted by National Cancer InstExpand Collapse -
Training opportunity at
#NIH - Aging#Research Summer Institute http://go.usa.gov/4tEB - deadline 3/22#geriatrics#gerontologyRetweeted by National Cancer InstExpand Collapse -
New opportunity to co-develop NCI therapeutic agents for certain types of cancer. http://1.usa.gov/WXbPXq
Retweeted by National Cancer InstExpand Collapse -
Have you considered becoming a bone marrow or blood stem cell donor? Watch as
@SerenaMarsh takes you thru donation. http://bit.ly/UITSM6 -
From http://cancer.gov , some facts about bone marrow transplantation: http://www.cancer.gov/cancertopics/factsheet/Therapy/bone-marrow-transplant?cid=YTncigov …
-
.
@BeTheMatch connects patients with matched donors for life-saving#marrow transplants. Make a difference! Visit http://www.BeTheMatch.org
@theNCI hasn't tweeted yet.
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
Flag this media
This has already been marked as containing sensitive content.